Stock Market 16 February 2026

Lichen International Stock Trades Higher Ahead of Nasdaq Open
····

Lichen International Stock Trades Higher Ahead of Nasdaq Open

Lichen International Limited shares were up in early U.S. trading after a choppy Tuesday session. The small Nasdaq-listed China financial-services stock continued a strong move, though there was little new company news out to explain the demand. The stock traded at $1.52, up 14 cents, or about 10% over the last close, according to market data. Shares opened Tuesday at $1.32 and swung from $1.26 to $1.71, Yahoo Finance data showed. Volume was around 543,580 shares.
June 3, 2026
Xero share price jumps 7.6% after a fresh 52-week low — what investors watch next
···

Xero share price jumps 7.6% after a fresh 52-week low — what investors watch next

Sydney, Feb 16, 2026, 17:35 AEDT — The session wrapped up with the market now closed. Xero Ltd jumped 7.6% to close at A$79.06 on Monday, snapping back after hitting a 52-week low just last Friday. Shares moved in a A$74.90 to A$79.33 range through the session. Still, the stock sits around 59% under its 12-month high. Xero's next annual report lands May 14.
February 16, 2026
Qube share price jumps after Macquarie-led $11.7bn takeover deal signed — what to watch next
···

Qube share price jumps after Macquarie-led $11.7bn takeover deal signed — what to watch next

Sydney, Feb 16, 2026, 17:32 AEDT — Trading shifted into after-hours. Qube Holdings climbed 3.3% on Monday, closing at A$5.01 after the logistics firm announced it had secured a binding agreement to go private at A$5.20 per share. The stock touched an all-time high of A$5.05 during the day—still ending roughly 4% below the buyout price. https://www.investing.com/equities/qube-logistics-holdings
February 16, 2026
CSL shares rebound after neffy nasal spray approval as buyback rolls on
····

CSL shares rebound after neffy nasal spray approval as buyback rolls on

Sydney, February 16, 2026, 17:01 AEDT — The session has ended. CSL Ltd picked up 1.4% by Monday’s close, recouping a slice of last week’s drop. The move followed news that its Seqirus arm secured Australian approval for the neffy adrenaline nasal spray, alongside a fresh update on the company’s share buyback. Shares wrapped up at A$152.17, though that’s still roughly 15.6% below where they stood five sessions ago.
February 16, 2026
1 … 107 108 109 110 111 … 127